Idris Bahce
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 26
- Lung Cancer Diagnosis and Treatment 21
- Oncology 37
- Cancer Immunotherapy and Biomarkers 25
- Co-authors
- Joachim G.J.V. Aerts (4 shared papers)Willemijn S.M.E. Theelen (2 shared papers)Heike Peulen (2 shared papers)Egbert F. Smit (30 shared papers)Anna-Larissa N. Niemeijer (6 shared papers)Adrianus J. de Langen (3 shared papers)Vincent van der Noort (4 shared papers)Daphne W. Dumoulin (1 shared paper)
- Journals
- Lung Cancer (15 papers)Journal of Thoracic Oncology (7 papers)Annals of Oncology (6 papers)Journal of Nuclear Medicine (6 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Idris Bahce
96 papers receiving 2.7k citations
Idris Bahce's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 884
- Cancer Research 411
- Radiology, Nuclear Medicine and Imaging 455
- Immunology 318
Countries citing papers authored by Idris Bahce
This map shows the geographic impact of Idris Bahce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idris Bahce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idris Bahce more than expected).
Fields of papers citing papers by Idris Bahce
This network shows the impact of papers produced by Idris Bahce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idris Bahce. The network helps show where Idris Bahce may publish in the future.
Co-authors
The 25 scholars most cited alongside Idris Bahce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2019 | 680 |
| 2 | Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Hit paper breakdown → | 2020 | 373 |
| 3 | 2012 | 260 | |
| 4 | 2015 | 98 | |
| 5 | 2012 | 92 | |
| 6 | 2021 | 66 | |
| 7 | 2020 | 61 | |
| 8 | 2021 | 52 | |
| 9 | 2021 | 50 | |
| 10 | 2018 | 44 | |
| 11 | 2014 | 44 | |
| 12 | 2021 | 38 | |
| 13 | 2023 | 33 | |
| 14 | 2020 | 33 | |
| 15 | 2023 | 33 | |
| 16 | 2021 | 33 | |
| 17 | 2023 | 31 | |
| 18 | 2022 | 31 | |
| 19 | 2016 | 31 | |
| 20 | 2015 | 30 |
About Idris Bahce
Idris Bahce is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (26 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (14 papers), Medical Imaging Techniques and Applications (12 papers), Radiomics and Machine Learning in Medical Imaging (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (884 citations), Cancer Research (411 citations), Radiology, Nuclear Medicine and Imaging (455 citations) and Immunology (318 citations). Idris Bahce has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Joachim G.J.V. Aerts, Willemijn S.M.E. Theelen, Heike Peulen, Egbert F. Smit, Anna-Larissa N. Niemeijer, Adrianus J. de Langen, Vincent van der Noort, Daphne W. Dumoulin, Jeltje F. de Vries and Ferry Lalezari. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Annals of Oncology, Journal of Nuclear Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.